Development of drugs for Epstein–Barr virus using high-throughput in silico virtual screening

Author： Li Ning   Thompson Scott   Jiang Hualiang   Lieberman Paul M   Luo Cheng  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.5, Iss.12, 2010-12, pp. : 1189-1203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-throughput and in silico screenings in drug discovery

By Phatak Sharangdhar S   Stephan Clifford C   Cavasotto Claudio N  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 947-959

Informa Healthcare

Access to resources Recommend Favorite

Design and in silico screening of inhibitors of the cholera toxin

By Zhang Guangtao  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 923-938

Informa Healthcare

Access to resources Recommend Favorite

In silico screening strategies for novel inhibitors of parasitic diseases

By Ferreira Rafaela S   Guido Rafael VC   Andricopulo Adriano D   Oliva Glaucius  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 481-489

Informa Healthcare

Access to resources Recommend Favorite

In silico analysis of antifungal peptides

By Soltani Saeed   Keymanesh Keykhosrow   Sardari Soroush  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 837-847

Informa Healthcare

Access to resources Recommend Favorite

Recent development in high-throughput bioanalytical support for in vitro ADMET profiling

By Shou Wilson Z   Zhang Jun  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 321-336

Informa Healthcare

Access to resources Recommend Favorite